Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 59, Issue 117, 2012, Pages 1512-1515

  Kim, Yeon Dae ^a   Hwang, Shin ^a   Lee, Young Joo ^a   Kim, Ki Hun ^a   Ahn, Chul Soo ^a   Park, Kwang Min ^a   Moon, Deok Bog ^a   Ha, Tae Yong ^a   Song, Gi Won ^a   Jung, Dong Hwan ^a   Park, Se Ra ^a   Hong, Hea Nam ^a   Lee, Sung Gyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; HTERT mrna; Recurrence; Resection; RT PCR

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84865171434     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10342     Document Type: Article

References (14)

1. Matsumura M, Niwa Y, Kato N, et al.: Detection of αfetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20:1418-1425.
2. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R: Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994; 106:239-242.
3. Miura N, Horikawa I, Nishimoto A, et al.: Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997; 93:56-62.
4. Chen XQ, Bonnefoi H, Pelte MF, et al.: Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6:3823-3826.
5. Zhou L, Liu J, Luo F: Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12:1175-1181.
6. Miura N, Maeda Y, Kanbe T, et al.: Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005; 11:3205-3209.
7. Lee SG, Hwang S, Moon DB, et al.: Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008; 14:935-945.
8. Ito T, Takada Y, Ueda M, et al.: Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007; 13:1637-1644.
9. Witzigmann H, Geissler F, Benedix F, et al.: Prospective evaluation of circulating hepatocytes by á-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131:34-43.
10. Ijichi M, Takayama T, Matsumura M, et al.: α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35:853-860.
11. Ding X, Yang LY, Huang GW, et al.: Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis. World J Gastroenterol 2005; 11:2656-2661.
12. Kar S, Carr BI: Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21:403-407.
13. Koh MS, Chung YH, Song IH, et al.: Albumin mRNA in peripheral bloods as a marker of extrahepatic metastasis in patients with hepatocellular carcinoma. Korean J Gastroenterol 1999; 33:240-251.
14. Barbu V, Bonnand AM, Hillaire S, et al.: Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology 1997; 26:1171-1175.